Dongfang Baitai makes its debut at the 3rd Beijing International Pharmaceutical and Health Innovation Exhibition.
[Summary Description]
From October 29 to 31, the “2018 Third Beijing International Medical Health Innovation Exhibition” (IMHI2018), hosted by the Beijing Pharmaceutical Industry Association, was held at the China National Convention Center in Beijing. With the theme “Openness, Innovation, and Development,” the exhibition brought together hundreds of companies to showcase the remarkable achievements made in China’s pharmaceutical and healthcare sectors since the country’s reform and opening-up. Oriental Baitai was invited to participate.
From October 29 to 31, the “2018 Third Beijing International Medical and Health Innovation Exhibition” (IMHI2018), hosted by the Beijing Pharmaceutical Industry Association, was held at the China National Convention Center in Beijing. With the theme “Openness, Innovation, and Development,” the exhibition brought together hundreds of companies to showcase the remarkable achievements made in China’s pharmaceutical and healthcare sectors since the country’s reform and opening-up. Oriental Baitai was invited to participate.
2018 marked the 40th anniversary of China’s reform and opening-up. To foster the development of the pharmaceutical and healthcare industries, implement an innovation-driven development strategy, and enhance the sector’s technological advancement and innovative capacity, the conference brought together cutting-edge, high‑tech products from across the pharmaceutical and health‑care fields. The exhibition featured scientific and technological innovations as well as state-of-the-art products spanning chemical formulations, biopharmaceuticals, modern Chinese medicine, traditional Chinese medicinal herbs, drug R&D, and pharmaceutical services.
The exhibition also hosted a series of high-level forums, project roadshows, promotional events, and other activities centered on “policy interpretation, industry analysis, cutting-edge technologies, and product promotion.”
At the exhibition, the “Beijing·Yizhuang” booth stood out prominently, with the Yizhuang Economic-Technological Development Area showcasing its pharmaceutical and health industries, cutting-edge technological innovations, and the latest R&D products, thereby highlighting the development strength and potential driven by scientific and technological advancement.
Beijing Dongfang Baitai Biotechnology Co., Ltd., as a cutting-edge, high-tech enterprise in the biopharmaceutical sector of the Yizhuang Economic-Technological Development Zone, was invited to showcase at the exhibition, drawing numerous visitors and generating an enthusiastic on-site atmosphere.
Founded in 2011 and located in the Yizhuang Development Zone, Dongfang Baitai covers an area of approximately 60,000 square meters. It is a high-tech enterprise specializing in the research, development, and manufacturing of innovative antibody therapeutics, with a primary focus on novel biopharmaceutical products for the treatment and prevention of major diseases.
At present, biotechnology‑based drugs are a major focus and priority in global pharmaceutical R&D. Over the years, Dongfang Baitai has initiated and advanced more than 20 biotech drug development programs, spanning multiple therapeutic areas including oncology, diabetes, autoimmune disorders, and ophthalmic diseases. To date, six of these candidates have entered clinical trials.
The company’s antibody R&D and manufacturing base covers over 100 mu of land and is equipped with three 200-L cell culture fermentation systems. It also includes a 3×3,000-L mammalian cell large-scale batch production line currently under construction, as well as a bacterial/yeast production line, among other antibody‑related facilities. The company has established a suite of cutting-edge, innovative technology platforms for antibody R&D and production.
Looking ahead, Dongfang Baitai will remain committed to advancing China’s biopharmaceutical sector and enhancing public health. Upholding the core values of “Responsibility, Quality, Innovation, and Health,” we will continuously strengthen our capacity for independent innovation, harnessing the latest breakthroughs in biotechnology to serve the pharmaceutical industry. We are dedicated to providing patients with cutting-edge, safe, and effective medicines, and we look forward to partnering with you to shape the future of biopharmaceuticals.
A warm welcome to Vice Mayor Lin Keqing for his visit and guidance at Dongfang Baitai.
On October 24, 2016, Beijing Vice Mayor Lin Keqing and his delegation visited Beijing Dongfang Baitai Biotechnology Co., Ltd. and Baitai Bio-pharmaceutical Co., Ltd., conducted an in-depth review of the companies’ R&D progress, inspected the production workshops on-site, and engaged in cordial discussions.
Leave a Message Online Online Message